What is synovial fluid?
Synovial fluid is the viscous, plasma-derived ultrafiltrate that fills diarthrodial joint cavities. This page covers its composition, the pathways studied in it, and the research models used to investigate it.
What is synovial fluid?
Synovial fluid is the viscous, non-Newtonian fluid that occupies the cavity of diarthrodial (synovial) joints, tendon sheaths and bursae. It is also called joint fluid or synovia. It is not a secretion of a gland but a dialysate of blood plasma to which hyaluronic acid, lubricin and plasma proteins are added by the synovial membrane; its water and electrolyte content therefore tracks plasma, while its protein content is lower and its hyaluronic acid content is locally produced. The evidence block for this page does not supply a sequence, formula or molecular weight for synovial fluid as a whole, and none is asserted here.
Research on synovial fluid centres on the innate immune signalling that governs its cellular and cytokine content, in particular the NLRP3 inflammasome and its adaptor TXNIP, together with the cytokine axis running through TNF-alpha and IL-1beta [1][3].
Research Studies
REJENERA and the NLRP3-TXNIP-iNOS axis in a rat osteoarthritis model
REJENERA, a multi-component bioflavonoid-based formula, was tested for its effect on osteoarthritis and chondroprotection by regulating the NLRP3-TXNIP-iNOS axis and inflammation. The formula contains primarily olive leaf bioflavonoids (ZeyEX, quercetin and luteolin), S-allylcysteine, palmitoylethanolamide, L-proline, hyaluronic acid and boron. In the study, osteoarthritis was established in rats by intra-articular injection of monosodium iodoacetate (3 mg) into the right knee joint, and REJENERA was compared with ZeyEX, NPROC (collagen-rich eggshell membrane combined with olive leaf extract) and ibuprofen [1]. This is an animal model; findings in it are not findings in humans.
Hyaluronic acid injection and TNF-alpha and IL-1beta in knee osteoarthritis
A registered study is designed to determine the effect of intra-articular hyaluronic acid injection therapy on pre- and post-treatment TNF-alpha and IL-1beta levels and on methylation changes in blood and synovial fluid in patients with knee osteoarthritis, compared with a placebo group. The same study is designed to evaluate the effects of hyaluronic acid injection on pain, functional status and quality of life, and to relate those effects to changes in TNF-alpha and IL-1beta [3].
Collagen peptide supplementation and connective tissue remodelling after total knee arthroplasty
A registered trial examines the effects of collagen peptide supplementation on connective tissue remodelling, functional outcomes and wound healing after total knee arthroplasty (TKA). Recruitment is performed by checking the calendar for scheduled TKA procedures more than 8 weeks ahead, with clinic staff screening the electronic medical record for basic inclusion and exclusion criteria and either contacting patients directly or passing contact information to the principal investigator; eligibility is verified by telephone and consent is taken electronically through REDCap [2].
Autologous bone marrow aspirate and combined LAM plus LP-PRP in knee osteoarthritis
The ABLE OA trial is a Health Canada authorised (phase II/III) multi-centre, prospective, double-blinded, randomised, placebo-controlled adaptive trial evaluating two minimally manipulated autologous cellular preparations: bone marrow aspirate (BMA) injection, and combined lipoaspirate micronized (LAM) plus leukocyte-poor platelet-rich plasma (LP-PRP) injections, for the treatment of knee osteoarthritis. BMA, LAM from lipoaspirate and LP-PRP from whole blood are prepared using the Cervos Marrow Cellution Bone Marrow Aspiration System, the Cervos LIPO-PRO Adipose Transfer System and the Cervos KEYPRP Platelet Separator System respectively [4].
Serum and synovial markers in periprosthetic joint infection
Total joint replacement is an increasingly effective orthopaedic procedure, but failure due to aseptic or septic loosening remains an important problem, often driven by patient predisposing factors that determine the need for revision surgery. Against the still-open questions about the diagnostic accuracy of serum and synovial fluid markers in periprosthetic joint infection (PJI), a diagnostic clinical study in patients hospitalised for revision surgery aims to evaluate the diagnostic accuracy and cost-effectiveness of combining serum and/or synovial markers in the diagnosis of PJI [6].
Alpha-defensin and synovial proteins in paediatric septic arthritis
Differentiating septic arthritis from other causes of joint inflammation in paediatric patients is challenging and of the utmost importance, because septic arthritis requires surgical debridement as part of the treatment regimen. The current gold standard for diagnosing septic arthritis in children is a positive synovial fluid culture, but joint cultures may take several days to return; if a bacterial infection is present, immediate surgical intervention is required to prevent lasting articular cartilage damage, and surgeons frequently must decide whether to debride a joint before culture results are available. No single laboratory test or clinical feature reliably makes that distinction, which is the gap a study of alpha-defensin and synovial proteins is designed to address [8].
Acthar and synovial inflammation in rheumatoid arthritis
A registered study assigns patients with rheumatoid arthritis to receive either Depo Medrol or Acthar. Synovial biopsy, blood draws, synovial fluid aspiration and physician assessments are performed before and after initiating treatment [7].
Borrelia B-cell diagnostics and synovial-adjacent immune sampling
The BRILLIANT study is a single-centre, prospective observational study in children with Lyme disease, assessing the immune response against Borrelia burgdorferi. Its main objectives include development of a Bb-specific ASC ELISpot as a new test method for diagnosis of early Lyme disease. The stated rationale is an urgent unmet clinical need for a better diagnostic tool for early Lyme disease, because the current standard two-tier testing has low sensitivity in recently infected patients and may show false positive results in recovered patients due to long-term persistence of antibodies against Bb [5].
Comparison of synovial-fluid research models
| Model or population | Intervention or marker studied | Fluid or tissue sampled | Source |
|---|---|---|---|
| Rat knee, monosodium iodoacetate-induced OA | REJENERA vs ZeyEX, NPROC, ibuprofen | Joint tissue (animal model) | [1] |
| Human knee OA | Intra-articular hyaluronic acid vs placebo | Blood and synovial fluid; TNF-alpha, IL-1beta, methylation | [3] |
| Human, after total knee arthroplasty | Collagen peptide supplementation | Connective tissue remodelling and wound healing outcomes | [2] |
| Human knee OA | BMA vs saline; LAM + LP-PRP vs saline | Autologous cellular preparations | [4] |
| Human, revision joint surgery | Serum and synovial marker panels | Serum and synovial fluid | [6] |
| Paediatric patients | Alpha-defensin and synovial proteins | Synovial fluid culture and proteins | [8] |
| Human rheumatoid arthritis | Acthar vs Depo Medrol | Synovial biopsy, blood, synovial fluid | [7] |
| Children with Lyme disease | Bb-specific ASC ELISpot | Immune response sampling | [5] |
Supporting reports on synovial fluid in other settings
Two further reports inform the wider picture without being the subject of a section here. One investigated the short-term effects of intra-articular allogenic platelet-rich plasma in the equine lipopolysaccharide model of joint inflammation, a randomised controlled trial in which a preliminary study using a 0.0625 ng LPS dose was performed in the middle carpal joint and compared within animal to a saline control to confirm that synovitis was induced [9]. The other examined the association between smoking history and inflammatory biomarkers in the synovial fluid of patients undergoing arthroscopic knee surgery for meniscal injury, on the basis that smoking has been linked to alterations in cellular inflammatory pathways and adverse outcomes in orthopaedic procedures, while how patient smoking affects the intra-articular microenvironment in symptomatic meniscal tears was unclear [10].
If you are reading this for personal health reasons
The materials described on this page are supplied for laboratory research use only. We do not provide dosing information or medical guidance of any kind. Anyone considering a compound for their own use should speak to a licensed clinician.
Sources
- [1] REJENERA, a multi-component bioflavonoid-based formula, alleviates osteoarthritis and provides chondroprotection by regulating the NLRP3-TXNIP-iNOS axis and inflammation: a comparative study with olive leaf nutraceuticals and ibuprofen. https://europepmc.org/article/PMC/PMC13525066
- [2] Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing After Total Knee Arthroplasty (TKA). https://clinicaltrials.gov/study/NCT05823727
- [3] The Effect of Hyaluronic Acid Injection on TNF-Alpha and IL-1β in Knee Osteoarthritis. https://clinicaltrials.gov/study/NCT06960564
- [4] Autologous BMA vs Saline and LAM + LP-PRP vs Saline Evaluations in Knee OA. https://clinicaltrials.gov/study/NCT05517434
- [5] Borrelia B-cell Diagnostics. https://clinicaltrials.gov/study/NCT06045416
- [6] Periprosthetic Joint Infections: Diagnostic Accuracy and Cost-effectiveness Analysis of Serum and Synovial Markers. https://clinicaltrials.gov/study/NCT04858217
- [7] The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis. https://clinicaltrials.gov/study/NCT03511625
- [8] Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis. https://clinicaltrials.gov/study/NCT03704766
- [9] Investigation into the Short-Term Effects of Intra-Articular Allogenic PRP in the Equine LPS Model of Joint Inflammation: A Randomised Control Trial. https://pubmed.ncbi.nlm.nih.gov/42651882/
- [10] The Effect of Smoking History on Inflammatory Biomarkers in Synovial Fluid of Patients Undergoing Arthroscopic Knee Surgery for Meniscal Injury. https://pubmed.ncbi.nlm.nih.gov/42359612/